Immuron Ltd has released a press release.
NASH Phase II Trial Reaches 50% Recruitment Milestone
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Immuron
- Immuron Announces E-Commerce Agreement with QBID in China
- US Distribution Reach Expanded through McKesson
- US Travelan Sales Network Widened by Allocation Inc Ptnrship
- Expansion of US Travelan Sales Following CVS Pharmacy Launch
- Immuron Improves Hadasit Royalty Terms
Later from Immuron
- Immuron Announces $6M Rights Issue Offer
- Immuron Rights Issue Offer Booklet (May 2016)
- Travelan to Reach Upto 1.5M New US Customers via Magellans
- Travelan and Protectyn Are Now Available For Sale in China
- IMC Signs Shigella Vaccine Developmt Agreement with US Army
Follow Immuron into a list and get an email when it puts out news.
Follow Immuron